MDGL — Madrigal Pharmaceuticals Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Madrigal Pharmaceuticals Inc (MDGL), worth $161.72M combined. Over the quarter 2 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $131.16M | 0.37% | -15.6% |
| Renaissance | $24.67M | 0.03% | -36.1% |
| IMC | $5.82M | 0.05% | +39.2% |
| Emerald | $37.59K | 0.00% | -99.8% |
| Persistent | $29.00K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.